Unacylated Ghrelin Promotes Skeletal Muscle Regeneration Following Hindlimb Ischemia Via SOD-2-mediated MiR-221/222 Expression
Overview
Authors
Affiliations
Background: Surgical treatment of peripheral artery disease, even if successful, does not prevent reoccurrence. Under these conditions, increased oxidative stress is a crucial determinant of tissue damage. Given its reported antioxidant effects, we investigated the potential of unacylated-ghrelin (UnAG) to reduce ischemia-induced tissue damage in a mouse model of peripheral artery disease.
Methods And Results: We show that UnAG but not acylated ghrelin (AG) induces skeletal muscle regeneration in response to ischemia via canonical p38/mitogen-actived protein kinase signaling UnAG protected against reactive oxygen species-induced cell injuries by inducing the expression of superoxide dismutase-2 (SOD-2) in satellite cells. This led to a reduced number of infiltrating CD68(+) cells and was followed by induction of the myogenic process and a reduction in functional impairment. Moreover, we found that miR-221/222, previously linked to muscle regeneration processes, was up-regulated and negatively correlated with p57(Kip2) expression in UnAG-treated mice. UnAG, unlike AG, promoted cell-cycle entry in satellite cells of mice lacking the genes for ghrelin and its receptor (GHSR1a). UnAG-induced p38/mitogen-actived protein kinase phosphorylation, leading to activation of the myogenic process, was prevented in SOD-2-depleted SCs. By siRNA technology, we also demonstrated that SOD-2 is the antioxidant enzyme involved in the control of miR-221/222-driven posttranscriptional p57(Kip2) regulation. Loss-of-function experiments targeting miR-221/222 and local pre-miR-221/222 injection in vivo confirmed a role for miR-221/222 in driving skeletal muscle regeneration after ischemia.
Conclusions: These results indicate that UnAG-induced skeletal muscle regeneration after ischemia depends on SOD-2-induced miR-221/222 expression and highlight its clinical potential for the treatment of reactive oxygen species-mediated skeletal muscle damage.
Lee T, Shen W, Chen Y, Lai T, Lin S, Lin S Autophagy. 2024; 21(2):374-393.
PMID: 39245438 PMC: 11760231. DOI: 10.1080/15548627.2024.2395799.
Kim H, Ranjit R, Claflin D, Georgescu C, Wren J, Brooks S Aging Cell. 2024; 23(12):e14323.
PMID: 39223708 PMC: 11634730. DOI: 10.1111/acel.14323.
Maiullari S, Cicirelli A, Picerno A, Giannuzzi F, Gesualdo L, Notarnicola A Int J Mol Sci. 2023; 24(23).
PMID: 38068954 PMC: 10706358. DOI: 10.3390/ijms242316631.
Pozzi G, Presta V, Masselli E, Condello G, Cortellazzi S, Arcari M Cells. 2023; 12(13).
PMID: 37443826 PMC: 10340168. DOI: 10.3390/cells12131792.
Chernyavskij D, Pletjushkina O, Kashtanova A, Galkin I, Karpukhina A, Chernyak B Antioxidants (Basel). 2023; 12(3).
PMID: 36978858 PMC: 10044935. DOI: 10.3390/antiox12030602.